Real-World Use of Loteprednol Etabonate 0.5%/Tobramycin 0.3% Ophthalmic Suspension for the Treatment of Ocular Surface Inflammatory Conditions
James E Deom,1,2 Shane Kannarr,3 Patrick Vollmer4,5 1The Dry Eye Center of Northeastern Pennsylvania, Hazleton, PA, USA; 2Hazleton and Stroudsburg Eye Specialists, Hazle Township, PA, USA; 3Kannarr Eye Care, LLC, Pittsburg, KS, USA; 4Vita Eye Clinic, Shelby, NC, USA; 5Synvenio Group, Shelby, NC, USA...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2022-11-01
|
| Series: | Clinical Ophthalmology |
| Subjects: | |
| Online Access: | https://www.dovepress.com/real-world-use-of-loteprednol-etabonate-05tobramycin-03-ophthalmic-sus-peer-reviewed-fulltext-article-OPTH |